Ignite Creation Date:
2024-05-06 @ 3:21 PM
Last Modification Date:
2024-10-26 @ 1:48 PM
Study NCT ID:
NCT04606732
Status:
RECRUITING
Last Update Posted:
2023-10-13
First Post:
2020-10-27
Brief Title:
CardioVascular Disease Progression and Prognosis in COVID-19
Sponsor:
University of Bologna
Organization:
University of Bologna
Study Overview
Official Title:
Cardiovascular Clinical Features and Cardiovascular Therapies in the Development Progression and Outcome of Patients With SARS-Cov-2 Related Pneumonia
Status:
RECRUITING
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CVP-Covid19
Brief Summary:
The CVP-COVID19 registry is both a retrospective and prospective study design in order to identify predictors of cardiovascular disease progression and mortality for COVID-19 The registry enrolls consecutive patients with positive microbiological tests for SARS-CoV-2 admitted to an academic hospital in northern Italy for worsening of COVID-19 symptoms The study does not test any new diagnostic or therapeutic approach Patients are treated according to good clinical practice Patients characteristics including medical history with particular attention to cardiovascular and pneumological risk factors features of physical examination results laboratory and radiological tests and treatments pre- and in-hospital are related with patient outcome Logistic analysis univariate multivariate and propensity are performed in order to identify factors associated with disease progression Primary endpoint mortality
Detailed Description:
Members of the Steering Committee
Olivia Manfrini Università di Bologna Italy Raffaele Bugiardini Università di Bologna Italy Stefano Nava Università di Bologna Italy Elisabetta Poluzzi Università di Bologna Italy Maria Carla Re Università di Bologna Italy Caterina Vocale Policlinico SantOrsola Study Coordinator Edina Cenko Università di Bologna Italy
Olivia Manfrini Università di Bologna Italy Raffaele Bugiardini Università di Bologna Italy Stefano Nava Università di Bologna Italy Elisabetta Poluzzi Università di Bologna Italy Maria Carla Re Università di Bologna Italy Caterina Vocale Policlinico SantOrsola Study Coordinator Edina Cenko Università di Bologna Italy
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None